AY-ApoE813

N/A

Report date: 2023/02/28 17:51:25
NME

Base Information

Drug NameAY-ApoE813
Drug Alias NameAY-ApoE813
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionApoE and APP interaction blockers
TargetsApolipoprotein EBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAnyu Kampo Pharmaceutical (Huainan) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnyu Kampo Pharmaceutical (Huainan) Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A